Recent events
Recent events tied to this brand in public sources.
Back to profile2 entries
2026
Lundbeck reportedly seeks to acquire US pharma company Xeris
Medwatch reports that Lundbeck is seeking to acquire the US pharmaceutical company Xeris. The report is attributed to media and the source does not state that a deal has been confirmed or completed.
2020
Lundbeck ends development of foliglurax
Lundbeck decided to terminate development of foliglurax after the drug failed to meet the primary and a key secondary measure in a phase 2 study.